Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,879,258 papers from all fields of science
Search
Sign In
Create Free Account
argpyrimidine
Known as:
N-delta-(5-hydroxy-4,6-dimethylpyrimidin-2-yl)-L-ornithine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Ornithine
Pyrimidines
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Degradation of oxidized and glycoxidized collagen: role of collagen cross-linking.
K. Nowotny
,
T. Grune
Archives of Biochemistry and Biophysics
2014
Corpus ID: 8321605
Highly Cited
2011
Highly Cited
2011
Accumulation of argpyrimidine, a methylglyoxal-derived advanced glycation end product, increases apoptosis of lens epithelial cells both in vitro and in vivo
Junghyun Kim
,
O. Kim
,
Chan-Sik Kim
,
E. Sohn
,
K. Jo
,
Jin Sook Kim
Experimental and Molecular Medicine
2011
Corpus ID: 684723
The formation of advanced glycation end products (AGEs) has been considered to be a potential causative factor of injury to lens…
Expand
2010
2010
Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively-aged mice.
C. Tatone
,
Mc Carbone
,
+5 authors
F. Amicarelli
Journal of Biological Regulators and Homeostatic…
2010
Corpus ID: 41332582
Reproductive dysfunction with ageing has been so far extensively characterized in terms of depletion of ovarian follicles and…
Expand
2007
2007
Gas-phase spectroscopy of protonated 3-OH kynurenine and argpyrimidine. comparison of experimental results to theoretical modeling.
L. Kessel
,
I. Nielsen
,
A. Bochenkova
,
K. Bravaya
,
L. H. Andersen
Journal of Physical Chemistry A
2007
Corpus ID: 10903458
The aging process of the human lens is associated with accumulation of chromophores and fluorophores that impair visual function…
Expand
Highly Cited
2006
Highly Cited
2006
Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cells
C. Schalkwijk
,
J. V. van Bezu
,
R. C. van der Schors
,
K. Uchida
,
C. Stehouwer
,
V. V. van Hinsbergh
FEBS Letters
2006
Corpus ID: 945882
Highly Cited
2006
Highly Cited
2006
Effect of methylglyoxal modification and phosphorylation on the chaperone and anti‐apoptotic properties of heat shock protein 27
T. Oya-Ito
,
Bingfen Liu
,
R. Nagaraj
Journal of Cellular Biochemistry
2006
Corpus ID: 25722048
Heat shock protein 27 (Hsp27) is a stress‐inducible protein in cells that functions as a molecular chaperone and also as an anti…
Expand
2005
2005
Impact of UVR-A on whole human lenses, supernatants of buffered human lens homogenates, and purified argpyrimidine and 3-OH-kynurenine.
L. Kessel
,
S. Kalinin
,
V. Soroka
,
M. Larsen
,
L. Johansson
Acta ophthalmologica
2005
Corpus ID: 42459901
PURPOSE Yellow chromophores and fluorescent compounds accumulate in the lens with age. Some of these compounds are…
Expand
Highly Cited
2004
Highly Cited
2004
Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy.
D. Raj
,
G. Lim
,
M. Levi
,
C. Qualls
,
S. Jain
American Journal of Kidney Diseases
2004
Corpus ID: 12099346
BACKGROUND The histologic picture of chronic allograft nephropathy (CAN) resembles early arteriosclerotic lesion. Oxidative…
Expand
2003
2003
Methylglyoxal modifies heat shock protein 27 in glomerular mesangial cells
A. K. Padival
,
J. Crabb
,
R. Nagaraj
FEBS Letters
2003
Corpus ID: 38467660
2001
2001
High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells
Pius S. Padayatti
,
Chunling Jiang
,
M. Glomb
,
K. Uchida
,
R. Nagaraj
Current Eye Research
2001
Corpus ID: 34939858
Purpose. To determine if high concentrations of glucose applied to cultured bovine retinal endothelial cells (BRE cells) would…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE